Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PROTEOMICS -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (137)	10/17/2000 2:13:18 AM
From: scaram(o)uche	Respond to of 539

I know Coutts. I did a due diligence job on LJPC about five years ago, when I was still consulting. He answered all of my questions honestly -- with pro-company spin, but honestly and fully. By the time I left, I made my call with certainty. Straight shooter, pharma background, extremely bright/professional -- and their NMR group was active and good. I'm way over my head with modeling and the derivation of leads, but (1) there are other companies that are talking about having pre-existing libraries to fit a given type of protein, and (2) I wouldn't sell Coutts short -- he'll be good at sticking his nose into the middle of this stuff and bringing out competive projects, IMO. Doesn't mean that I'm ready to go out and throw cash at an IPO. <g>